Responsible for the HIV Business Unit (Commercial & Marketing), Product Lauch, Brand Strategies, People Development plans.* Successful Launch of an antiretroviral, having the highest Patient Share of the Region (Latam) * Double sales of the HIV Business Unit 2022 Vs. 2021 * Gain for the first time the leadership with antiretroviral in the HIV total Market* Ahead Together International Award for doubling the HIV Business In Colombia * International Regional Award for Being accountable for Impact * Gold Award in the "One GSK Meeting" for the best Launch of Dovato in the region* Silver Award in the "One GSK Meeting" for the great synergy with the Vaccine Franchise. * EM Talent Forum Award Recognition

Responsible for the strategy definition and execution of GSK & ViiV Healthcare HIV Portfolio. Responsible for aligning the Marketing, Access, PSP & Government Strategies of the Business Unit. Responsible for the execution of the launch process of HIV Products pipeline (4 Products)• Double digit growth in sales and units Vs. LY 2021• Internal & External Successful Lunch of DOVATO new HIV medicine.• GSK Leading HIV Market• Double digit growth 10% and 35% in core products (2021 Vs. 2020)• E-learning curse execution

Responsible for the strategy definition and execution of Benlysta (Belimumab) a biologic medicine indicated for Systemic Lupus Erythematosus disease. Access plan implementation, PSP program, close relationship with Key Rheumatologist, real world evidence (Cost effective studies), Value base healthcare programs with customers. Ensure business performance is being delivered according to KPIs such as yearly sales, market shares, Gross Margin, A&P, and marketing RO• Double digit growth in sales and units Vs. LY 2019o Values 32% Units 43%• Double digit growth in enrolment patients’ rate Vs. LY 2019• Increase of 11points of Market share in units and 3 points in values vs. main competitor.• Successful launch of “LupusCampus” an e-learning platform with the certification of the Pan-American society of Rheumatology• Patient support program Launch

Responsible for the strategy definition and execution of Central Nervous System, Anti-infective and Urology portfolio in Latin America region. Ensure business performance is being delivered according to KPIs such as yearly sales, market shares, Gross Margin, A&P, and marketing ROI. Assure discipline on promo grid activities optimizing SG&A on Core brands, identify, define and initiate additional growth initiatives. Support initiatives that can increase Classic Established products profitability through Net Revenue Management without loss of competitiveness. Act as escalation point and advocate with Business for the Markets and vice versa to enable smooth functioning of the countries and performance against plan. Support Markets with knowledge, resources etc. needed to support sales, including aligning Business and Market priorities to deliver against highest impact opportunities. Act as pivoting element between different functions such as Global Marketing Team, Finance, Supply chain, and Commercial.Achievements:• 2020 Business plan creation for priority markets in collaboration with the Global team defining opportunities, strategies and tactics. • Brand Strategy, key messages and tactic plan alignment in Latin America focusing on key priorities, optimizing approval process and assuring 2020 business plan execution. • Argentina, Colombia and Mexico deep dive workshops changing brands trends. Ex. Colombia: 3 days deep dive increasing sales in 12% and CAGR(5yrs) of 8% achieving positive Evolution Index taking advantage of the healthcare system dynamics, price regulations and national formulary product inclusion or 2020. Price-Volume analysis. • Outstanding classic Established products performance during the year with double digit growth (15,3%) and positive evolution index 104 YTD Agosto19’ in growth markets (Brazil, Mexico and Argentina) • Emerging Market award nomination of the project “Congress Highlights” Urology European Congress executed in March 2019.

Responsible for mapping the alternatives and opportunities in the market, seeking to reduce costs in the production / supply chain, in addition acting as a project manager for Brazil and articulating the implementation of the new Pharma Operating Model, harmonizing the strategic plan, promotional grid and investments.Achievements:1. Strategic Planning for Brazil defining the objectives and key deliverable with the Brazil leadership team.

PMO for Latam responsible for supporting the Senior Leadership Team (VPGMs) to address growth objectives within Pharma business in LATAM, setting a successful & efficient planning process and delivering effective deployment. Establish more robust alignment throughout organizational levels with regards strategic objectives and key targets. Assigned Brazil as core market to develop the strategic planning process aligning business units (Biotech and Pharma business) and support functions to the company objectives. Achievements:• 2018 Latam Strategic Planning Process for Latin-American• Senior Vice President agenda management and presentations for Townhalls in countries and reviews with headquarters and external meetings (Government, Congresses) • Preparation of GSK CEO visit to the region and Brazil. Leading the visit with Consumer PMO and Global Strategy office VP. Alignment of all templates and CEO requirements.• Balance Score Card methodology implementation for performance reviews• BSC and KPIs dashboard was replicated by Emerging Markets using the same methodology to review the business• Strategic Boards for Vaccines, Respiratory and HIV.• Country Business reviews across Latin America base on KPIs and action plans.• Brand Plans alignment for all Franchises customized for Latin-American • Develop the Strategic Planning Process for Brazil (2019) Biotech and Pharma Business.

Responsible for the Respiratory Franchise Strategy for Colombia and product launch rediness.(Seretide, Flixotide, Ventilan/Salbutan)Product manager of alergy portfolio(Avamys, Zyrtec, Nazidil) Responsible for the Digital Marketing Stratey for the respiratory FranchiseChampion for Colombia "EMAP Marketers tool"Relvar product Launch in Colombia

Responsible for the marketing plans & strategy of Womens Health Portfolio, Respiratory Portfolio & Vertigo.(Verum, Belara, Gianda, B-cort, Timalar, Novex)

Responsible for the marketing plans & strategy of Womens Health Portfolio & Vertigo.

• Responsible for developing strategic planning initiatives, such as new business cases, strategic plan and market analysis. • Coordinate activities prior to product launch, line extensions, new products and expansion alternatives portfolio (33 products).• Local leader of the regional initiative to optimize marketing investments "Commercial Innovtion Toolkit", this activity allows directors and product managers to make a better resource allocation. • Responsible for managing primary market research (from conception of needs, supplier selection, construction of the survey and monitoring the contract).

• Responsible for developing management strategies to improve profitability in companies, reduce costs, increase revenue, improve operations. • In charge in helping clients to identify where the main drivers of costs located to improve their performance.• Design of the operational model that responds to the value promise (ETB project) • Development of an excellence model for all the areas of the company, based on the best standards, frameworks, and global best practices. • Re - design of the organizational chart of all the company.• Development and design of the Marketing department, based on global best practices.

• Worked with a team of 3 students from Stanford University Performing Research for Panasonic. • Promoted and place the Panasonic brand name worldwide as a green company. • Promoted and sell Panasonic products through innovative sales strategies.• Performed user testing, benchmarking, needfinding, and background research; designed and built rapid prototypes to explore new approaches to energy management systems.